First biotech drug to treat psoriasis.
Mitchell
Peter
P
D000077944:Alefacept; D017277:Drug Approval / Q000331:legislation & jurisprudence; D006801:Humans; D007880:Legislation, Drug; D011565:Psoriasis / Q000188:drug therapy*; D011993:Recombinant Fusion Proteins / Q000592:standards* / Q000627:therapeutic use*; D012307:Risk Factors; D014481:United States
D011993:Recombinant Fusion Proteins; D000077944:Alefacept